"MingKe Pharmaceutical (688373.SH) Shareholder Genie Pharma Publicly Solicits Voting Rights to Oppose Certain Proposals"

Zhtng Cijng APP News, Mengke Pharmaceutical (688373.SH) announced that the company's shareholder Genie Pharma voted against multiple proposals at the company's second extraordinary general meeting in 2025. Genie Pharma holds a total of 71.5728 million shares of the company, accounting for 10.92% of the total shares. The period for collecting voting rights is from September 25, 2025, to October 6, 2025. Reasons for the opposition by the collector include uncertainties in Hijng Pharmaceutical's participation in the capital increase, risks of sales channel and personnel confusion, slower than expected progress in investment projects, uncertainties in using Hijng Pharmaceutical's production capacity to enhance profitability, and limited synergies in the research and development field.